Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Reversal of virus-induced systemic shock and respiratory failure by blockade of the lymphotoxin pathway

Nature Medicine volume 5, pages 1370–1374 (1999)Cite this article

Abstract

At present, little is known about the pathogenesis of acute virus-induced shock and pulmonary failure. A chief impediment in understanding the underlying disease mechanisms and developing treatment strategies has been the lack of a suitable animal model. This study describes a mouse model of virus-induced systemic shock and respiratory distress, and shows that blockade of the lymphotoxin beta receptor pathway reverses the disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Infection of NZB mice with LCMV-13 results in mortality.
Figure 2: Histological profile of LCMV-13 infection in NZB mice.
Figure 3: Blockade of the LTβR signaling pathways substantially improves survival rates among NZB mice infected with LCMV-13.
Figure 4: A single-dose treatment of lethally infected mice after establishment of viral infection leads to a significant increase (P = 0.
Figure 5: Blockade of the LTβR pathway results in a decrease in LCMV-13 specific CD8 T cells.
Figure 6: Depletion of CD8+ T cells, not CD4+ T cells, reverses the lethal effects of LCMV-13 infection in NZB mice.
Figure 7: Mice that survive LCMV-13 infection clear the virus infection and show no signs of disease pathology.

Similar content being viewed by others

References

  1. Lacy, M.D. & Smego, R.A. Viral hemorrhagic fevers. Adv. Pediatr. Infect. Dis. 12, 21–53 (1996).

    CAS  PubMed  Google Scholar 

  2. Peters, C.J. in Viral Pathogenesis (ed. Nathanson, N.) 779–799 (Lippincott-Raven, Philiadelphia, 1997).

    Google Scholar 

  3. No author given. Hantavirus pulmonary syndrome—Colorado and New Mexico, 1998. Morbid. Mortal. Weekly Report 47, 449–452 (1998).

  4. Toro, J. et al. An outbreak of hantavirus pulmonary syndrome, Chile, 1997. Emerg. Infect. Dis. 4, 687–694 (1998).

    Article  CAS  Google Scholar 

  5. Zaki, S.R. et al. Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease. Am. J. Pathol. 146, 552–579 (1995).

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Zaki, S.R. et al. Retrospective diagnosis of hantavirus pulmonary syndrome, 1978-1993: implications for emerging infectious diseases. Arch. Pathol. Lab. Med. 120, 134–139 (1996).

    CAS  PubMed  Google Scholar 

  7. Nolte, K.B. et al. Hantavirus pulmonary syndrome in the United States: a pathological description of a disease caused by a new agent. Hum. Pathol. 26, 110–120 (1995).

    Article  CAS  Google Scholar 

  8. Hallin, G.W. et al. Cardiopulmonary manifestations of hantavirus pulmonary syndrome. Crit. Care Med. 24, 252–258 (1996).

    Article  CAS  Google Scholar 

  9. Talal, N. & Steinberg, A.D. The pathogenesis of autoimmunity in New Zealand black mice. Curr. Top. Microbiol. Immunol. 64, 79–103 (1974).

    CAS  PubMed  Google Scholar 

  10. Ahmed, R. & Oldstone, M.B. Organ-specific selection of viral variants during chronic infection. J. Exp. Med. 167, 1719–1724 (1988).

    Article  CAS  Google Scholar 

  11. Matloubian, M., Kolhekar, S.R., Somasundaram, T. & Ahmed, R. Molecular determinants of macrophage tropism and viral persistence: importance of single amino acid changes in the polymerase and glycoprotein of lymphocytic choriomeningitis virus. J. Virol. 67, 7340–7349 (1993).

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Sheehan, K.C., Ruddle, N.H. & Schreiber, R.D. Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors. J. Immunol. 142, 3884–3893 (1989).

    CAS  PubMed  Google Scholar 

  13. Wong, G.H. & Goeddel, D.V. Tumour necrosis factors alpha and beta inhibit virus replication and synergize with interferons. Nature 323, 819–22 (1986).

    Article  CAS  Google Scholar 

  14. Beutler, B., Milsark, I.W. & Cerami, A.C. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229, 869–871 (1985).

    Article  CAS  Google Scholar 

  15. Mackay, F. et al. Cytotoxic activities of recombinant soluble murine lymphotoxin-alpha and lymphotoxin-alpha beta complexes. J. Immunol. 159, 3299–3310 (1997).

    CAS  PubMed  Google Scholar 

  16. Crowe, P.D. et al. A lymphotoxin-beta-specific receptor. Science 264, 707–710 (1994).

    Article  CAS  Google Scholar 

  17. Hober, D. et al. Serum levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-1 beta (IL-1 beta) in dengue-infected patients. Am. J. Trop. Med. Hyg. 48, 324–231 (1993).

    Article  CAS  Google Scholar 

  18. Bethell, D.B. et al. Pathophysiologic and prognostic role of cytokines in dengue hemorrhagic fever. J. Infect. Dis. 177, 778–782 (1998).

    Article  CAS  Google Scholar 

  19. Force, W.R. et al. Mouse lymphotoxin-beta receptor. Molecular genetics, ligand binding, and expression. J. Immunol. 155, 5280–5288 (1995).

    CAS  PubMed  Google Scholar 

  20. Miller, G.T. et al. Specific interaction of lymphocyte function-associated antigen 3 with CD2 can inhibit T cell responses. J. Exp. Med. 178, 211–222 (1993).

    Article  CAS  Google Scholar 

  21. Browning, J.L. et al. Characterization of surface lymphotoxin forms. Use of specific monoclonal antibodies and soluble receptors. J. Immunol. 154, 33–46 (1995).

    CAS  PubMed  Google Scholar 

  22. Abe, Y. et al. Studies of membrane-associated and soluble (secreted) lymphotoxin in human lymphokine-activated T-killer cells in vitro. Lymphokine Cytokine Res. 11, 115–121 (1992).

    CAS  PubMed  Google Scholar 

  23. Ware, C.F., Crowe, P.D., Grayson, M.H., Androlewicz, M.J. & Browning, J.L. Expression of surface lymphotoxin and tumor necrosis factor on activated T, B, and natural killer cells. J. Immunol. 149, 3881–3888 (1992).

    CAS  PubMed  Google Scholar 

  24. Browning, J.L. et al. Lymphotoxin beta, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface. Cell 72, 847–856 (1993).

    Article  CAS  Google Scholar 

  25. Mauri, D.N. et al. LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity 8, 21–30 (1998).

    Article  CAS  Google Scholar 

  26. Montgomery, R.I., Warner, M.S., Lum, B.J. & Spear, P.G. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 87, 427–436 (1996).

    Article  CAS  Google Scholar 

  27. Sayer, W.J., Entwhisle, G., Uyeno, B. & Bignall, R.C. Cortisone therapy of early epidemic hemorrhagic fever: a preliminary report. Ann. Int. Med. 42, 839–851 (1955).

    Article  CAS  Google Scholar 

  28. Mertz, G.J., Hjelle, B.L., Williams, T.M. & Koster, F.T. Host responses in the hantavirus cardiopulmonary syndrome. in Emergence and Control of Rodent-Borne Viral Diseases 43, p.43 (Marcel Merieux Foundation, Annecy, France, 1998).

    Google Scholar 

  29. Ahmed, R., Salmi, A., Butler, L.D., Chiller, J.M. & Oldstone, M.B. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence. J. Exp. Med. 160, 521–540 (1984).

    Article  CAS  Google Scholar 

  30. Dialynas, D.P. et al. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. J. Immunol. 131, 2445–2451 (1983).

    CAS  PubMed  Google Scholar 

  31. Sourdive, D.J. et al. Conserved T cell receptor repertoire in primary and memory CD8 T cell responses to an acute viral infection. J. Exp. Med. 188, 71–82 (1998).

    Article  CAS  Google Scholar 

  32. Altman, J.D. et al. Phenotypic analysis of antigen-specific T lymphocytes. Science 274, 94–96 (1996).

    Article  CAS  Google Scholar 

  33. Zajac, A.J. et al. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188, 2205–2213 (1998).

    Article  CAS  Google Scholar 

  34. Murali-Krishna, K. et al. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8, 177–187 (1998).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank P. Greer and T. Ferebee for their technical assistance in generating and staining tissue sections, and E. Halloran for advice on statistical analysis. This work was funded in part by NIH grants AI09866, AI30048 and NS21496. All animals used in experiments described here were treated in accordance with Emory University's guidelines.

Author information

Authors and Affiliations

  1. Emory Vaccine Center and Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, 30322, Georgia, USA

    Maryann T. Puglielli, John D. Altman & Rafi Ahmed

  2. Biogen Incorporated, 14 Cambridge Center, Cambridge, 02142, Massachusetts, USA

    Jeffrey L. Browning

  3. Schering-Plough Research Institute, Lafayette, 07848, New Jersey, USA

    Avery W. Brewer

  4. Department of Pathology, Washington University School of Medicine, St. Louis, 63110, Missouri, USA

    Robert D. Schreiber

  5. Infectious Disease Pathology Activity, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, 30322, Georgia, USA

    Wun-Ju Shieh & Sherif R. Zaki

  6. Division of Virology, Department of Neuropharmacology, The Scripps Research Institute, La Jolla, 92037, California, USA

    M.B.A. Oldstone

Authors
  1. Maryann T. Puglielli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jeffrey L. Browning
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Avery W. Brewer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Robert D. Schreiber
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Wun-Ju Shieh
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. John D. Altman
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M.B.A. Oldstone
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Sherif R. Zaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Rafi Ahmed
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rafi Ahmed.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Puglielli, M., Browning, J., Brewer, A. et al. Reversal of virus-induced systemic shock and respiratory failure by blockade of the lymphotoxin pathway. Nat Med 5, 1370–1374 (1999). https://doi.org/10.1038/70938

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/70938

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing